Podcasts

David Zweig, published author and science journalist based in New York, joins the show to tackle one specific topic pertaining to the COVID-19 pandemic: mask mandates for children in schools.

Emily Landon, MD, Executive Medical Director, Infection Prevention and Control, University of Chicago, makes her long-awaited return to the show to provide an update on the status of COVID-19 in the US.

Samer Al Hadidi, MD, assistant professor in the multiple myeloma program, University of Arkansas, shares his own human experience of receiving an unfortunate diagnosis as an immigrant going through residency and through fellowship, all while dealing with the loss of a close relative.

To debate the utility and appropriateness of real-world evidence against clinical trials for treating patients with hematologic malignancies, Chadi welcomes back Aaron Goodman, MD, hematologist, University of California San Diego, and Alan Skarbnik, MD, director of the lymphoma and CLL program, Novant Health (Charlotte, NC), as well as invites first-time guest Liz Brem, MD, assistant clinical professor of hematology, UC Irvine.

Chadi hosts Graham Collins, MBBS, MA, MRCP, FRCPath, DPhil, hematology consultant in the UK, for a broad discussion aimed to simplify an often complicated disease: Hodgkin lymphoma.

Chadi re-invites Dave Feldman, senior software engineer and entrepreneur, and Ethan Weiss, MD, cardiologist at UC San Francisco, to rehash a Twitter argument on secondary prevention for heart attacks for patients with high LDL. Should patients receive statins or should they not? What does the data show and where is the controversy, if any? How does diet play a role? What about the infamous KETO diet?

Ramaswamy Govindan, MD, Anheuser Busch Endowed Chair in Medical Oncology, Washington University School of Medicine in St. Louis, provides the condensed oral history of thoracic oncology – dating from the late 1990s to the present day.

arvard Medical School, joins the show to discuss his book “Committed: Dispatches from a Psychiatrist in Training” and the struggles that psychiatry trainees face today.